Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response

Davis "The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors" J. Immunother. Cancer (2019) 10.1186/s40425-019-0768-9

[3]

Das "TIM3 and its Role in Regulating Anti-Tumor Immunity" Immunol. Rev. (2017) 10.1111/imr.12520

[4]

LAG3 (CD223) as a cancer immunotherapy target

Lawrence P. Andrews, Ariel E. Marciscano, Charles G. Drake et al.

Immunological Reviews 2017 10.1111/imr.12519

[5]

Chauvin "TIGIT in Cancer Immunotherapy" J. Immunother. Cancer (2020)

[6]

Johnson "ARC-7: Randomized phase 2 study of domvanalimab + zimberelimab ± etrumadenant vs zimberelimab in first-line, metastatic, PD-L1–high non–small cell lung cancer" ASCO Plenary Series (2022)

[7]

Kuang "Construction of a T-cell exhaustion-related gene signature for predicting prognosis and immune response in hepatocellular carcinoma" Aging (Albany NY) (2023)

[8]

Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer

Colt A. Egelston, Weihua Guo, Jiayi Tan et al.

JCI Insight 2022 10.1172/jci.insight.153963

[9]

Hsu "Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma" Liver Cancer (2021) 10.1159/000515305

[10]

Zheng "Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing" Cell (2017) 10.1016/j.cell.2017.05.035

[11]

Chi "T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing" Front. Immunol. (2023) 10.3389/fimmu.2023.1137025

[12]

Zhang "Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy" EBioMedicine (2022) 10.1016/j.ebiom.2022.104207

[13]

Nixon "Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer" Immunity (2022) 10.1016/j.immuni.2022.10.002

[14]

Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing

Xinyi Guo, Yuanyuan Zhang, Liangtao Zheng et al.

Nature Medicine 2018 10.1038/s41591-018-0045-3

[15]

Kim "Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer" Genome Med. (2020) 10.1186/s13073-020-00722-9

[16]

Andrews "Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups" Nat. Immunol. (2019) 10.1038/s41590-019-0512-0

[17]

Jin "Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection" Proc. Natl. Acad. Sci. USA (2010) 10.1073/pnas.1009731107

[18]

Joller "LAG-3, TIM-3, and TIGIT: Distinct functions in immune regulation" Immunity (2024) 10.1016/j.immuni.2024.01.010

[19]

Chen "TNF in the era of immune checkpoint inhibitors: friend or foe?" Nat. Rev. Rheumatol. (2021) 10.1038/s41584-021-00584-4

[20]

Ahmad "Targeted colonic claudin-2 expression renders resistance to epithelial injury, induces immune suppression, and protects from colitis" Mucosal Immunol. (2014) 10.1038/mi.2014.21

[21]

Cai "Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy" J. Hematol. Oncol. (2023) 10.1186/s13045-023-01499-1

[22]

Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab

Nadeem Riaz, Jonathan J. Havel, Vladimir Makarov et al.

Cell 2017 10.1016/j.cell.2017.09.028

[23]

Motzer "Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial" Nat. Med. (2020) 10.1038/s41591-020-1044-8

[24]

Loriot "Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance" Ann. Oncol. (2021) 10.1016/j.annonc.2021.08.1748

[25]

Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer

Gabriela Bindea, Bernhard Mlecnik, Marie Tosolini et al.

Immunity 2013 10.1016/j.immuni.2013.10.003

[26]

Pomaznoy "GOnet: a tool for interactive Gene Ontology analysis" BMC Bioinf. (2018) 10.1186/s12859-018-2533-3

[27]

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E.A. Eisenhauer, P. Therasse, J. Bogaerts et al.

European Journal of Cancer 2009 10.1016/j.ejca.2008.10.026

[28]

Rimm "A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer" JAMA Oncol. (2017) 10.1001/jamaoncol.2017.0013

[29]

Milbury "Clinical and analytical validation of FoundationOne®CDx, a comprehensive genomic profiling assay for solid tumors" PLoS One (2022) 10.1371/journal.pone.0264138

[30]

Bessede "TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non-Small Cell Lung Cancer" Clin. Cancer Res. (2024) 10.1158/1078-0432.ccr-23-2566

Metrics

28

Citations

30

References

Details

Published: Dec 01, 2024
Vol/Issue: 5(12)
Pages: 101831
License: View

Authors

Department of Medical Oncology Hôpital Saint‐André Bordeaux University Hospital‐CHU Bordeaux France

B

Berengère Dadone-Montaudie

Department of Medical Oncology, Institut Bergonié , Bordeaux,

Ezogelin Oflazoglu Gruyters

Medical Oncology Department, Centre Hospitalier de la Côte Basque , Bayonne,

Funding

Roche

Cite This Article

Jean-Philippe Guegan, Florent Peyraud, Berengère Dadone-Montaudie, et al. (2024). Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response. Cell Reports Medicine, 5(12), 101831. https://doi.org/10.1016/j.xcrm.2024.101831

Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response

You May Also Like